Trials / Completed
CompletedNCT01254487
e-BioMatrix PostMarket Surveillance Registry
A Postmarket Surveillance Registry of the BioMatrix Drug-eluting Stent
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,121 (actual)
- Sponsor
- Biosensors Europe SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the e-BioMatrix PMS registry is to capture clinical data of the BioMatrix (Biolimus A9-Eluting) stent system in relation to safety and effectiveness.
Conditions
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2012-09-01
- Completion
- 2014-09-01
- First posted
- 2010-12-06
- Last updated
- 2019-05-06
Locations
9 sites across 3 countries: Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01254487. Inclusion in this directory is not an endorsement.